Cryolife, Inc.

CRY

$29.19

+27.6% (1 year change)

Avg closing price

Price range

Market Cap

$1.16 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$16.13 - $32.34

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

-89.33x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $1.16 Billion
Enterprise Value $1.42 Billion
Dividend Yield $0.00 (0.0%)
1 Year Return +27.6%
52-Week High $32.34
52-Week Low $16.13
Beta 0.96
Outstanding Shares 39.1 Million
Avg 30 Day Volume 182 Thousand

Valuation

P/E Ratio -89.33
PEG 167.71
Earnings per Share -$0.34
Price to Sales Ratio 4.87
Price to Book Ratio 4.17
Revenue to Enterprise Value 5.5
EBIT to Enterprise Value 279.43
Total Debt to Enterprise Value 0.22
Debt to Equity 1.05

Profitability

Revenue $258 Million
Gross Profit $171 Million
EBIT $5.07 Million
Net Income -$13 Million
Profit Margin -5.05%
Quarterly Earnings Growth (YoY) -53.3%
Return on Equity -4.38%
Return on Assets -1.64%
Return on Invested Capital 0.69%

News

CryoLife Reports Fourth Quarter and Full Year 2020 Financial Results

CryoLife Reports Fourth Quarter and Full Year 2020 Financial Results

ATLANTA, Feb. 11, 2021 /PRNewswire/ -- Fourth Quarter and Recent Business Highlights: Achieved total revenues of $67.9 million in the fourth quarter 2020 versus $69.7 million in the fourth quarter ...

PR Newswire PR Newswire, 4 months ago
Worldwide Hemostasis and Tissue Sealing Agents Industry to 2027 - Featuring Baxter, Cohera Medical and CryoLife Among Others

Worldwide Hemostasis and Tissue Sealing Agents Industry to 2027 - Featuring Baxter, Cohera Medical and CryoLife Among Others

DUBLIN, Dec. 30, 2020 /PRNewswire/ -- The "Hemostasis and Tissue Sealing Agents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" report has been added to Res...

PR Newswire PR Newswire, 6 months ago
CryoLife to Host Webcast Discussing PROACT Xa Clinical Trial on December 7, 2020

CryoLife to Host Webcast Discussing PROACT Xa Clinical Trial on December 7, 2020

ATLANTA, Nov. 19, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will host a webcast for investor...

PR Newswire PR Newswire, 7 months ago